Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of a self-directed lifestyle-based weight management program among patients with comorbid COPD and sleep apnea: a secondary analysis of the INSIGHT COPD trial.

Annals of the American Thoracic Society·2025
Same author

Increasing Residential Radon Testing Through Outreach to Families of Newborn Children in Pennsylvania: Evaluation of Intervention Outcomes, 2002-2023.

AJPM focus·2025
Same author

Characterizing the content and quality of internet resources on exercise training in Ehlers-Danlos Syndromes and generalized hypermobility spectrum disorder.

PloS one·2025
Same author

Changes in cardiovascular disease risk, lung function and other clinical health outcomes when people who smoke use e-cigarettes to reduce cigarette smoking: an exploratory analysis from a randomised placebo-controlled trial.

BMJ open·2025
Same author

Email outreach attracts the US policymakers' attention to climate change but common advocacy techniques do not improve engagement.

Communications earth & environment·2025
Same author

Epidemiology of idiopathic pulmonary fibrosis in central and Western Pennsylvania.

Respiratory research·2025

Related Experiment Video

Updated: Jun 30, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Incidental pleural-based pulmonary lymphangioma.

Michael G Benninghoff1, William U Todd, Rebecca Bascom

  • 1Penn State College of Medicine, Penn State Hershey Medical Center, 500 University Dr, H041, Hershey, PA 17033-2360, USA. mikebenninghoff@hotmail.com

The Journal of the American Osteopathic Association
|September 23, 2008
PubMed
Summary

This case report details a rare solitary pleural-based pulmonary lymphangioma, an incidental finding in a woman with chronic pain. The lesion, though fluorodeoxyglucose-avid, was not the cause of her symptoms.

Related Experiment Videos

Last Updated: Jun 30, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Area of Science:

  • Thoracic oncology
  • Diagnostic imaging
  • Surgical pathology

Background:

  • Benign thoracic lymphangiomas are uncommon mediastinal or pulmonary lesions.
  • They can be asymptomatic or cause symptoms due to compression of adjacent structures.
  • Management options include resection or sclerotherapy for symptomatic cases.

Observation:

  • A solitary pleural-based pulmonary lymphangioma was incidentally discovered in a 38-year-old woman.
  • The patient presented with chronic arm and shoulder pain.
  • Positron emission tomography (PET) showed the lesion was highly fluorodeoxyglucose-avid.

Findings:

  • Biopsy confirmed the lesion as benign lymphangioma.
  • Radiographic evaluation suggested the lymphangioma was unlikely to be the source of the patient's chronic pain.
  • This represents the first reported case of a solitary pleural-based pulmonary lymphangioma.

Implications:

  • Highlights the importance of considering rare diagnoses in thoracic imaging.
  • Demonstrates that highly fluorodeoxyglucose-avid lesions may not always correlate with symptoms.
  • Contributes to the literature on benign pulmonary and pleural neoplasms.